Explore more publications!
Wellness Focus Cayman Islands
Got News to Share?

Wellness Focus Cayman Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Focus Cayman Islands.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 11, 2026

Zymeworks Outlines Strategic Priorities and Outlook for 2026
Jan. 11, 2026

Zymeworks Outlines Strategic Priorities and Outlook for 2026

Indeterminate GlobeNewswire
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Jan. 11, 2026

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation

Indeterminate GlobeNewswire
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Jan. 11, 2026

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Indeterminate GlobeNewswire
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Jan. 11, 2026

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Indeterminate GlobeNewswire
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
Jan. 11, 2026

Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones

Indeterminate GlobeNewswire
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
Jan. 11, 2026

Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

Indeterminate GlobeNewswire
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
Jan. 11, 2026

MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
Jan. 11, 2026

Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results

Indeterminate GlobeNewswire
Exagen Inc. Announces Select Preliminary 2025 Financial Results
Jan. 11, 2026

Exagen Inc. Announces Select Preliminary 2025 Financial Results

Indeterminate GlobeNewswire
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Jan. 11, 2026

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
Jan. 11, 2026

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

Indeterminate GlobeNewswire
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
Jan. 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions